138 related articles for article (PubMed ID: 32118784)
1. Willingness to pay for a quality-adjusted life year among advanced non-small cell lung cancer patients in Viet Nam, 2018.
Ha TV; Hoang MV; Vu MQ; Hoang NT; Khuong LQ; Vu AN; Pham PC; Vu CV; Duong LH
Medicine (Baltimore); 2020 Feb; 99(9):e19379. PubMed ID: 32118784
[TBL] [Abstract][Full Text] [Related]
2. Willingness to pay per quality-adjusted life year for life-saving treatments in Thailand.
Nimdet K; Ngorsuraches S
BMJ Open; 2015 Oct; 5(10):e008123. PubMed ID: 26438135
[TBL] [Abstract][Full Text] [Related]
3. Willingness to Pay for a Quality-Adjusted Life Year among Gastrointestinal Cancer Patients at a Tertiary Hospital of Vietnam, 2022.
Tran BT; Tran TT; La NQ; Nguyen TTP; Nguyen MH; Huynh TMC; Vu HP
Asian Pac J Cancer Prev; 2024 May; 25(5):1725-1735. PubMed ID: 38809645
[TBL] [Abstract][Full Text] [Related]
4. A Contingent Valuation Study for Eliciting a Monetary Value of a Quality-Adjusted Life-Year in the General Greek Population.
Mavrodi A; Aletras V
Value Health Reg Issues; 2020 Sep; 22():36-43. PubMed ID: 32731168
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of willingness to pay per quality-adjusted life year for a cure: A contingent valuation method using a scenario-based survey.
Song HJ; Lee EK
Medicine (Baltimore); 2018 Sep; 97(38):e12453. PubMed ID: 30235732
[TBL] [Abstract][Full Text] [Related]
6. Willingness to pay for a quality-adjusted life year: an evaluation of attitudes towards risk and preferences.
Martín-Fernández J; Polentinos-Castro E; del Cura-González MI; Ariza-Cardiel G; Abraira V; Gil-LaCruz AI; García-Pérez S
BMC Health Serv Res; 2014 Jul; 14():287. PubMed ID: 24989615
[TBL] [Abstract][Full Text] [Related]
7. Willingness to pay for a quality-adjusted life-year: the individual perspective.
Bobinac A; Van Exel NJ; Rutten FF; Brouwer WB
Value Health; 2010 Dec; 13(8):1046-55. PubMed ID: 20825620
[TBL] [Abstract][Full Text] [Related]
8. An exploratory study to estimate cost-effectiveness threshold value for life saving treatments in western Iran.
Moradi N; Woldemichael A; Malekian P; Rotvandi DM; Rezaei S
Cost Eff Resour Alloc; 2020; 18():47. PubMed ID: 33110399
[TBL] [Abstract][Full Text] [Related]
9. A systematic review of studies eliciting willingness-to-pay per quality-adjusted life year: does it justify CE threshold?
Nimdet K; Chaiyakunapruk N; Vichansavakul K; Ngorsuraches S
PLoS One; 2015; 10(4):e0122760. PubMed ID: 25855971
[TBL] [Abstract][Full Text] [Related]
10. Co-financing for viral load monitoring during the course of antiretroviral therapy among patients with HIV/AIDS in Vietnam: A contingent valuation survey.
Nguyen QL; Nguyen LH; Tran BX; Phan HT; Le HT; Nguyen HD; Tran TD; Do CD; Nguyen CM; Thuc VT; Latkin C; Zhang MW; Ho RC
PLoS One; 2017; 12(2):e0172050. PubMed ID: 28199405
[TBL] [Abstract][Full Text] [Related]
11. Willingness to Pay for One Additional Quality Adjusted Life Year: A Population Based Survey from China.
Ye Z; Abduhilil R; Huang J; Sun L
Appl Health Econ Health Policy; 2022 Nov; 20(6):893-904. PubMed ID: 35934772
[TBL] [Abstract][Full Text] [Related]
12. Quality of life and utility in patients with non-small cell lung cancer. Quality-of-life Study Group of the Master 2 Project in Pharmacoeconomics.
Trippoli S; Vaiani M; Lucioni C; Messori A
Pharmacoeconomics; 2001; 19(8):855-63. PubMed ID: 11596837
[TBL] [Abstract][Full Text] [Related]
13. Exploring the willingness to pay for a quality-adjusted life-year in the state of Penang, Malaysia.
Shafie AA; Lim YW; Chua GN; Hassali MA
Clinicoecon Outcomes Res; 2014; 6():473-81. PubMed ID: 25364267
[TBL] [Abstract][Full Text] [Related]
14. Estimating Willingness to Pay for an Improved Service Delivery to Patients Referring Namazi Hospital Chemical Therapy Ward in Iran Using Contingent Valuation.
Kavosi Z; Jafari A; Keshtkaran V; Pourahmadi E
Asian Pac J Cancer Prev; 2018 Jul; 19(7):1817-1823. PubMed ID: 30049193
[TBL] [Abstract][Full Text] [Related]
15. Monetary Value of Quality-Adjusted Life Years (QALY) among Patients with Cardiovascular Disease: a Willingness to Pay Study (WTP).
Moradi N; Rashidian A; Rasekh HR; Olyaeemanesh A; Foroughi M; Mohammadi T
Iran J Pharm Res; 2017; 16(2):823-833. PubMed ID: 28979338
[TBL] [Abstract][Full Text] [Related]
16. Expanding co-payment for methadone maintenance services in Vietnam: the importance of addressing health and socioeconomic inequalities.
Tran BX; Nguyen QL; Nguyen LH; Phan HTT; Le HT; Tran TD; Vu TTM; Latkin CA
BMC Health Serv Res; 2017 Jul; 17(1):480. PubMed ID: 28701208
[TBL] [Abstract][Full Text] [Related]
17. Financial mobilization for antiretroviral therapy program: multi-level predictors of willingness to pay among patients with HIV/AIDS in Vietnam.
Tran BX; Fleming M; Nguyen CT; Latkin CA
AIDS Care; 2018 Dec; 30(12):1488-1497. PubMed ID: 30047280
[TBL] [Abstract][Full Text] [Related]
18. Estimating a WTP-based value of a QALY: the 'chained' approach.
Robinson A; Gyrd-Hansen D; Bacon P; Baker R; Pennington M; Donaldson C;
Soc Sci Med; 2013 Sep; 92():92-104. PubMed ID: 23849283
[TBL] [Abstract][Full Text] [Related]
19. Estimating a constant WTP for a QALY-a mission impossible?
Sund B; Svensson M
Eur J Health Econ; 2018 Jul; 19(6):871-880. PubMed ID: 28932914
[TBL] [Abstract][Full Text] [Related]
20. Estimation of loss of quality-adjusted life expectancy (QALE) for patients with operable versus inoperable lung cancer: adjusting quality-of-life and lead-time bias for utility of surgery.
Yang SC; Lai WW; Chang HY; Su WC; Chen HH; Wang JD
Lung Cancer; 2014 Oct; 86(1):96-101. PubMed ID: 25178685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
